Breaking News, Collaborations & Alliances

ABL, RD-Biotech Sign Strategic Partnership in Cell and Gene Therapy GMP Mfg.

This collaboration combines the strengths of both companies to offer a new and flexible end-to-end service to C> developers.

Author Image

By: Charlie Sternberg

Associate Editor

ABL, a pure play Contract Development and Manufacturing Organization (CDMO) with specialized expertise in the development and manufacturing of solutions for biopharma, and RD-Biotech, a CRO/CDMO providing custom services in development and production of plasmid DNA, monoclonal antibodies and recombinant proteins, have signed a strategic partnership in Cell and Gene Therapy (C>) GMP manufacturing.   This collaboration brings together RD-Biotech’s plasmid DNA (pDNA) GMP manufacturing services...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters